Dr. Reddy's Laboratories ...

NYSE: RDY · Real-Time Price · USD
14.15
0.04 (0.28%)
At close: Aug 15, 2025, 9:51 AM

Dr. Reddy's Laboratories Cash Flow Statement

Financials in INR. Fiscal year is April - March.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Net Income
57.24B 55.68B 60.48B 23.57B 19.15B
Depreciation & Amortization
17.06B 14.84B 12.5B 11.82B 12.8B
Stock-Based Compensation
424M 821M 397M 592M 584M
Other Working Capital
-6.95B 6.32B -5.2B -8.59B 1.59B
Other Non-Cash Items
-17.85B -21.92B -21.96B -2.69B 2.29B
Deferred Income Tax
19.54B 16.19B 15.3B 8.73B 9.18B
Change in Working Capital
-29.99B -20.18B -7.86B -13.91B -8.29B
Operating Cash Flow
46.43B 45.43B 58.87B 28.11B 35.7B
Capital Expenditures
-34.4B -27.43B -18.86B -19.05B -12.56B
Cash Acquisitions
-53.41B -12M n/a -326M -15.51B
Purchase of Investments
-254.46B -145.49B -136.17B -88.97B -75.42B
Sales Maturities Of Investments
279.58B 129.78B 112.81B 77.77B 79.53B
Other Investing Acitivies
-2.28B -8.16B 859M 4.19B 1.3B
Investing Cash Flow
-58.08B -40.28B -41.37B -26.39B -22.66B
Debt Repayment
23.2B -1.15B -1.01B 2.73B -697M
Common Stock Repurchased
-1.39B n/a n/a n/a -1.19B
Dividend Paid
-6.66B -6.65B -4.98B -4.15B -4.15B
Other Financial Acitivies
3.57B 3.23B -21.23B -1.34B 5.47B
Financial Cash Flow
18.91B -3.76B -26.86B -2.42B -298M
Net Cash Flow
7.49B 1.33B -9.07B 32M 12.86B
Free Cash Flow
12.03B 18B 40.01B 9.06B 23.14B